Koers Pangaea Oncology, S.A. BME
Aandelen
ES0105221008
Biotechnologie & Medisch Onderzoek
Omzet 2024 * | 13,8 mln. 14,94 mln. | Omzet 2025 * | 14,8 mln. 16,02 mln. | Marktkapitalisatie | 54,18 mln. 58,64 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -1 mln. -1,08 mln. | Nettowinst (verlies) 2025 * | - 0 | EV/omzet 2024 * | 4,32 x |
Nettoschuld 2024 * | 5,5 mln. 5,95 mln. | Nettoschuld 2025 * | 6,8 mln. 7,36 mln. | EV/omzet 2025 * | 4,12 x |
K/w-verhouding 2024 * |
-36,8
x | K/w-verhouding 2025 * |
-92
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 21,08% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | - | 01-01-07 | |
Founder | - | 01-01-07 | |
Founder | - | 01-01-07 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Founder | - | 01-01-07 | |
Founder | - | 01-01-07 | |
Founder | - | 01-01-07 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+29,03% | 48,16 mld. | |
-0,10% | 41,73 mld. | |
+43,45% | 41,03 mld. | |
-5,26% | 28,77 mld. | |
+11,48% | 25,59 mld. | |
-22,74% | 18,96 mld. | |
+9,06% | 12,92 mld. | |
+30,01% | 12,03 mld. | |
-1,51% | 11,77 mld. |